Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) EBT Margin (2011 - 2026)

Emergent BioSolutions (EBS) posted EBT Margin of 70.98% for Q2 2026, down 926.83% on a QoQ basis from 8.58% in Q1 2026, and down 5905.0% year-over-year from 1.22% in Q2 2025.

Analysis

Emergent BioSolutions (EBS) EBT Margin (2011 - 2026) Analysis & Trends

Emergent BioSolutions has reported EBT Margin for 16 years, with the latest figure at 70.98% in Q2 2026.

  • On a quarterly basis, EBT Margin fell 5905.0% year-over-year to 70.98% in Q2 2026; TTM through Jun 2026 was 18.96%, a 4135.0% decrease from a year earlier, with the FY2025 full-year figure at 11.15%, up 2484.0% from the prior year.
  • EBT Margin was 70.98% for Q2 2026 at Emergent BioSolutions, down from 8.58% in the prior quarter.
  • The five-year high for EBT Margin was 48.47% in Q3 2024, with the low at 105.93% in Q2 2024.
  • Average EBT Margin over 5 years is 26.73%, with a median of 19.15% recorded in 2022.
  • The sharpest annual moves came in 2023 and 2024: EBT Margin tumbled 9650 bps in 2023, then jumped 14677 bps in 2024.
  • Over 5 years, EBT Margin stood at 18.59% in 2022, then dropped by 6 bps to 19.7% in 2023, then advanced by 28 bps to 14.18% in 2024, then plunged by 141 bps to 34.1% in 2025, then slumped by 108 bps to 70.98% in 2026.
  • The last three EBT Margin figures came in at 70.98% (Q2 2026), 8.58% (Q1 2026), and 34.1% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 26.66%
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn 25.18%
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn -4.11%
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 29.63%
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn -4.34%
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 31.50%
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn 12.17%
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 18.33%
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn -70.98%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -70.98%
Mar 31, 2026 8.58%
Dec 31, 2025 -34.10%
Sep 30, 2025 24.92%
Jun 30, 2025 -11.92%
Mar 31, 2025 41.72%
Dec 31, 2024 -14.18%
Sep 30, 2024 48.47%
Jun 30, 2024 -105.93%
Mar 31, 2024 4.03%
Dec 31, 2023 -19.70%
Sep 30, 2023 -98.30%
Jun 30, 2023 -74.05%
Mar 31, 2023 -97.75%
Dec 31, 2022 -18.59%
Sep 30, 2022 -28.01%
Jun 30, 2022 -34.13%
Mar 31, 2022 -1.25%
Dec 31, 2021 34.97%
Sep 30, 2021 -15.89%
API Access

Emergent BioSolutions EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY